/
History and Organization Procyon Corporation ("Procyon" or the "Company") consolidates the operations of Procyon with AMERX Health Care Corporation("AMERX") and Sirius Medical Supply, Inc. ("Sirius"), its wholly-owned subsidiaries, for financial purposes. Collectively throughout this report, Procyon, Amerx and Sirius may be referred to as the "Company," "us," or "we" or "our." Procyon, a Colora…
The business is unprofitable at the operating level (-4.65% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 6.4%, steady but not accelerating. Margins contracted 2.6pp, which offsets some of the top-line progress.
ROIC dropped from -2.39% to -6.40%, capital efficiency is deteriorating. Negative free cash flow of -$125K. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$5M
▲ +6.4% YoY
Net Income (TTM)
-$341K
▼ -579.0% YoY
Op. Margin
-4.65%
▼ -2.6pp YoY
ROIC
-6.40%
▼ -4.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$125K
▼ -261.0% YoY
Op. Cash Flow (TTM)
-$61K
▼ -142.1% YoY
Net Debt
-$6K
Net Cash Position
Cash & Equiv.
$326K
5Y CAGR: +3.5%
Continue Research